HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

What’s Driving Sabana Industrial REIT’s 94.7% Occupancy In Q3 2025 — Its Highest In 12 Years

Sabana REIT's Record Quarter: 5 Surprising Insights from a Management Team on its Way...
SGX-LISTED COMPANIES

How Falling Demand Hit Aztech Global’s Profits Hard In Q3 2025

Profits Plunged 55%, But Here Are 4 Reasons Aztech Global is Quietly Building a...
SGX-LISTED COMPANIES

How Versalink Holdings Managed To Stay Cash-Positive Despite A Massive Half-Yearly Loss In 2025

How a Company Lost RM4.1 Million Yet Grew Its Bank Account: 5 Surprising Insights...
SGX-LISTED COMPANIES

Currency Volatility Wipes Out SHS Holdings 2025 Half-Year Gains

The SHS Holdings Paradox: How a 49% Revenue Boom Led to Deeper Losses It's a...
SGX-LISTED COMPANIES

TT International Posts 72% Loss In Q1 FY2026 Amid Ongoing Scheme Update

More Twists Than a Thriller: What One Financial Report Reveals About a Company's 15-Year...
SGX-LISTED COMPANIES

What Drove Abundante Limited’s Impressive Revenue Growth In HY2025

We Analyzed a Financial Report—Here Are 4 Surprising Secrets We Uncovered Introduction: The Hidden Stories...
SGX-LISTED COMPANIES

How Top Glove Staged A Remarkable Recovery In FY2025

5 Surprising Takeaways from Top Glove's Massive 2025 Comeback Just a year ago, the narrative...
SGX-LISTED COMPANIES

How Duty Free International Achieved Over 100% Profit Growth In Q2 2026

Introduction: We've delved into the latest 36-page interim report from Duty Free International Limited, a...
SGX-LISTED COMPANIES

Fortress Minerals Sees Revenue Rise But Profits Slashed In Q2 FY2026

Sales Are Up, Profits Are Down: The Surprising Story Hidden in a Mining Company's...
SGX-LISTED COMPANIES

Why Inbound Demand Fueled Tosei Corporation’s Q3 2025 Financial Performance

Hidden within the numbers of Tosei Corporation's latest financial results are surprising and powerful...
SGX-LISTED COMPANIES

Matex International’s EGM Halted By Injunction In 2025 First Half Report

We Read a 35-Page Financial Report. Here Are the 4 Most Surprising Things We...
SGX-LISTED COMPANIES

Doubt Looms Over China Environmental Resources Group’s Future In 2025 Annual Results

An Idle Forest, a Shrinking Tire Business, and an Existential Threat: The Bizarre Story...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...